Drugmaker to study pig kidney transplants in humans with groundbreaking trial
FDA clears United Therapeutics for human trials of pig-to-human kidney transplants. Trial involves gene-edited pig kidneys ...
AlphaGalileo1d
The ISSCR to Celebrate 20th Anniversary of iPSC Discovery in Kyoto, Japan
World-renowned stem cell scientists will gather in Kyoto, Japan for the International Society for Stem Cell Research (ISSCR) ...
Peptide Therapeutics Market To Reach $93 Million By 2033, Flourishing At A 7.2% CAGR
Peptide Therapeutics Market was valued at USD 47.2 Million in 2023, and is expected to reach USD 93.0 Million in 2033, at a CAGR of 7.2% NEW Y ...
H.C. Wainwright maintains buy rating on Tenaya Therapeutics stock
H.C. Wainwright analyst Joseph Pantginis maintained a Buy rating on Tenaya Therapeutics Inc (NASDAQ:TNYA), with a price target of $18.00. This aligns with the strong overall analyst consensus, as ...
Axogen Announces Appointment of Jesse Bishop as Vice President of Regulatory Affairs and Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
“We are pleased to welcome Jesse to the Axogen team," said Michael Dale, Chief Executive Officer, and Director, Axogen. "His extensive experience in regulatory strategy and deep understanding of the ...
Fintel on MSN4d
HC Wainwright & Co. Initiates Coverage of CRISPR Therapeutics (CRSP) with Buy Recommendation
Fintel reports that on February 3, 2025, HC Wainwright & Co. initiated coverage of CRISPR Therapeutics (NasdaqGM:CRSP) with a ...
Mena FN10d
Cell Therapy Regenerative Medicine Market Expected To Flourish At 15.78% CAGR To 170.0 Billion USD Gilead Sciences
Rapid growth fueled by advances in stem cell research and gene editing technologies. Cell Therapy Regenerative Medicine Market growth was valued at 45.46 Billion USD in 2023. Cell Therapy Regenerative ...
Finanznachrichten14d
PAGE Therapeutics AG: Clinical trial published in Nature Medicine shows proof of concept of PAGE's Therapeutics approach
BASEL, Switzerland, Jan. 24, 2025 /PRNewswire/ -- PAGE Therapeutics, a biotech company focused on tackling metastatic cancer spread at its root, is pleased to announce the publication of the ...
Business Wire18d
United Therapeutics Corporation to Feature Clinical Data Across its Commercial and Development Portfolio at the Pulmonary Vascular Research Institute 2025 Annual Congress
SILVER SPRING, Md. & RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--United Therapeutics Corporation (Nasdaq: UTHR), a public benefit corporation, today announced that five posters across its ...
Frontiers18d
Brief summary of the regulatory frameworks of regenerative medicine therapies
The rapid advancements in regenerative medicine (RM), including cell therapies ... This paper reviews the regulatory frameworks for RM across the United States, European Union, Japan, Canada, ...
Seeking Alpha22d
UTHR United Therapeutics Corporation
The overall quant rating is not an average of the factor grades listed. Instead, it gives greater weight to the metrics with the strongest predictive value.
Seeking Alpha22d
Sarepta Therapeutics: Guidance Suggests A Year Of Upside Likely
These companies valuations have fluctuated since - Exelixis' is now valued at $10.65bn, Genmab, $13.7bn, Alnylam, $32.4bn, BioMarin, $11.7bn, and United Therapeutics, $16.1bn, while Sarepta's ...